BHS: Catharina Muylaert received an award for the best poster presentation at the 37th General Annual Meeting of the Belgian Hematology Society (BHS) in La Hulpe, Belgium on February 4 – 5, 2022. She presented her poster entitled: ‘The de novo DNA methyltransferase 3B: A new promising target in multiple myeloma’.
BACR: For her poster entitled: ‘Targeting of DNMT3B in the plasma cell cancer multiple myeloma disturbs cancer cell growth and clonogenicity and boosts the anti-tumor activity of the proteasome inhibitor bortezomib’, Catharina Muylaert received the price of ‘First best poster award’ at the Belgian Association for Cancer Research (BACR) in Ghent, Belgium on September 30th, 2022.
EEHD: Catharina Muylaert presented her poster entitled: ‘The de novo DNA methyltransferase DNMT3B plays an important role in multiple myeloma cell growth, clonogenicity and drug response’ at the Epigenetics and Epigenomics in Health and Disease (EEHD) from 19 till 17 November, 2022 in Brussels, Belgium. For this poster presentation she received the 3rd prize.